J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 70 (1989), 1473-1481; DOI 10.1099/0022-1317-70-6-1473
© 1989 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fahey, K. J.
Right arrow Articles by Crooks, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fahey, K. J.
Right arrow Articles by Crooks, J.
Agricola
Right arrow Articles by Fahey, K. J.
Right arrow Articles by Crooks, J.

A Conformational Immunogen on VP-2 of Infectious Bursal Disease Virus that Induces Virus-neutralizing Antibodies that Passively Protect Chickens

Kevin J. Fahey, Katrina Erny and Jennifer Crooks

CSIRO Division of Animal Health, Animal Health Research Laboratory, Private Bag No. 1, P.O., Parkville, Victoria 3052, Australia

VP-2b, a major structural protein of infectious bursal disease virus (IBDV), and its precursor protein VP-2a were separated in a soluble form from the supernatant of ultracentrifuged viruses by using a monoclonal antibody specific for VP-3, the other major structural protein, to remove soluble VP-3 and remaining virus particles. The native VP-2a/2b inhibited the majority of virus-neutralizing (VN) activity in chicken anti-IBDV sera and chickens immunized with VP-2a/2b produced VN antibodies that passively protected susceptible chickens from infection. However, the separated VP2a/2b was not as immunogenic as intact virus particles. VP-2a/2b would appear to contain a conformational epitope which is destroyed by SDS and boiling and which may prove to be of critical importance in a subunit vaccine against type 1 IBDV.

Keywords: IBDV, immunogen, vaccine development

Received 25 July 1988; accepted 8 February 1989.


This article has been cited by other articles:


Home page
J. Virol.Home page
T. Letzel, F. Coulibaly, F. A. Rey, B. Delmas, E. Jagt, A. A. M. W. van Loon, and E. Mundt
Molecular and Structural Bases for the Antigenicity of VP2 of Infectious Bursal Disease Virus
J. Virol., December 1, 2007; 81(23): 12827 - 12835.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. A. Villanueva, J. L. Galaz, J. A. Valdes, M. M. Jashes, and A. M. Sandino
Genome Assembly and Particle Maturation of the Birnavirus Infectious Pancreatic Necrosis Virus
J. Virol., December 15, 2004; 78(24): 13829 - 13838.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Huang, S. Elankumaran, A. S. Yunus, and S. K. Samal
A Recombinant Newcastle Disease Virus (NDV) Expressing VP2 Protein of Infectious Bursal Disease Virus (IBDV) Protects against NDV and IBDV
J. Virol., September 15, 2004; 78(18): 10054 - 10063.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
Y. Dieye, A. J. W. Hoekman, F. Clier, V. Juillard, H. J. Boot, and J.-C. Piard
Ability of Lactococcus lactis To Export Viral Capsid Antigens: a Crucial Step for Development of Live Vaccines
Appl. Envir. Microbiol., December 1, 2003; 69(12): 7281 - 7288.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Tsukamoto, S. Saito, S. Saeki, T. Sato, N. Tanimura, T. Isobe, M. Mase, T. Imada, N. Yuasa, and S. Yamaguchi
Complete, Long-Lasting Protection against Lethal Infectious Bursal Disease Virus Challenge by a Single Vaccination with an Avian Herpesvirus Vector Expressing VP2 Antigens
J. Virol., May 3, 2002; 76(11): 5637 - 5645.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Brandt, K. Yao, M. Liu, R. A. Heckert, and V. N. Vakharia
Molecular Determinants of Virulence, Cell Tropism, and Pathogenic Phenotype of Infectious Bursal Disease Virus
J. Virol., December 15, 2001; 75(24): 11974 - 11982.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. R. Caston, J. L. Martinez-Torrecuadrada, A. Maraver, E. Lombardo, J. F. Rodriguez, J. I. Casal, and J. L. Carrascosa
C Terminus of Infectious Bursal Disease Virus Major Capsid Protein VP2 Is Involved in Definition of the T Number for Capsid Assembly
J. Virol., November 15, 2001; 75(22): 10815 - 10828.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
J. L. Martinez-Torrecuadrada, B. Lazaro, J. F. Rodriguez, and J. I. Casal
Antigenic Properties and Diagnostic Potential of Baculovirus-Expressed Infectious Bursal Disease Virus Proteins VPX and VP3
Clin. Vaccine Immunol., July 1, 2000; 7(4): 645 - 651.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1989 by the Society for General Microbiology.